Genetic suppression features ABHD18 as a Barth syndrome therapeutic target. - Masud SN; Srivastava A; Mero P; Echezarreta VS; Anderson E; van Buren L; Wei J; Taylor DT; Farias AG; Mikolajewicz N; Shaw A; Murareanu BM; et al. (Nature, 2025)